🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the effect and safety of NKTR-118 ...
Status
Completed
Location
Research Site
Start Date
2011-03
Trial ID
NCT01309841
This post-authorization observational safety study (PASS) monitors clinical...
Status
Terminated
Location
Research Site
Start Date
2016-09
Trial ID
NCT02813369
Treatments Being Tested
To characterize the pharmacokinetics (PK) of naloxegol after single oral do...
Status
Completed
Location
Odense University Hospital
Start Date
2014-11
Trial ID
NCT02099591
Treatments Being Tested
The purpose of this study is to evaluate the effect and safety of NKTR-118 ...
Status
Completed
Location
Research Site
Start Date
2011-03
Trial ID
NCT01323790
The purpose of this study is to compare the effect of NKTR-118 with placebo...
Status
Terminated
Location
Research Site
Start Date
2011-06
Trial ID
NCT01384292
The purpose of this study is to evaluate the effect and safety of NKTR-118 ...
Status
Completed
Location
Research Site
Start Date
2011-07
Trial ID
NCT01395524
This randomized pilot clinical trial studies the side effects and best dose...
Status
Terminated
Location
Anchorage Associates in Radiation Medicine
Start Date
2018-03-23
Trial ID
NCT03087708
Treatments Being Tested
This post-authorization observational safety study determines the character...
Status
Completed
Location
Research Site
Start Date
2015-08
Trial ID
NCT02813148
Treatments Being Tested
The purpose of this study is to determine whether patients with opioid indu...
Status
Completed
Location
Research Site
Start Date
2017-03-02
Trial ID
NCT03060512
Treatments Being Tested
This research study was being done to study the effect of codeine and Nalox...
Status
Completed
Location
Mayo Clinic in Rochester
Start Date
2016-07-01
Trial ID
NCT02737059
Treatments Being Tested